结晶
溶解度
吡罗昔康
溶剂
丙酮
化学
二氯甲烷
乙腈
乙酸乙酯
甲醇
溶解
有机化学
医学
病理
替代医学
作者
Iben Østergaard,Haiyan Qu
出处
期刊:Crystals
[MDPI AG]
日期:2021-12-11
卷期号:11 (12): 1552-1552
被引量:4
标识
DOI:10.3390/cryst11121552
摘要
In this work, the solubility of a non-steroidal anti-inflammatory drug (NSAID), piroxicam, is investigated. The polymorphic form II, which is the most stable form at room temperature, was investigated in seven different solvents with various polarities. It has been found that the solubility of piroxicam in the solvents is in the following order: chloroform > dichloromethane > acetone > ethyl acetate > acetonitrile > acetic acid > methanol > hexane. Crystallization of piroxicam from different solvents has been performed with evaporative crystallization and cooling crystallization; the effects of solvent evaporation rate and solute concentration have also been studied. Both form I and form II could be produced in cooling and evaporative crystallization, and no simple link can be identified between the operating parameters and the polymorphic outcome. Results obtained in the present work showed the stochastic nature of the nucleation of different polymorphs as well as the complexity of the crystallization of a polymorphic system.
科研通智能强力驱动
Strongly Powered by AbleSci AI